In addition, an auxiliary tumor cell killing mechanism that heavily relies on T-cell (or CAR-T) expressed FasL-mediated extrinsic apoptotic cytotoxicity of Fas+ cancer cells is critical in human clinical trials8. The gene discussed is FAS; the disease is neoplasm.